Open menu

Nanotechnology Business News

The latest product and company news

RSS Subscribe to our Nanotechnology Business News feed

CardioGenics to Continue Commercialization of its Magnetic Beads With Merck Chimie SAS

Merck recently notified CardioGenics that while it is refining its encapsulation of the CardioGenics beads, it will also test a batch of magnetic beads coated with CardioGenics' proprietary silver-coating and polymer encapsulation processes with the aim of commercializing the CardioGenics Encapsulated Beads while Merck Chimie is finalizing its owns proprietary encapsulation of the CardioGenics beads.

Posted: Feb 5th, 2011

Read more

Another Patent Licensed for PAL-M Super-resolution Technology

Together with the previously issued patents (U.S. 7,626,694, U.S. 7,828,695, U.S. 7,626,703 and U.S. 7,782,457) substantial systems and methods of super-resolution microscopy are now protected. These methods are based on the separation and localization of molecules to achieve resolution beyond the Abbe resolution limit.

Posted: Feb 4th, 2011

Read more

Izon Science Sponsors Gathering of World-leading Nanotechnologists in New Zealand

Nanotechnology company Izon Science, is putting its support behind a gathering of world-leading nanotechnologists, physicists and chemists in Wellington next week, as a gold sponsor and contributor. The Fifth International Conference on Advanced Materials and Nanotechnology (AMN-5), hosted by the MacDiarmid Institute, brings together an international gathering of experts to discuss new advances and opportunities in the advanced materials and nanotechnology fields.

Posted: Feb 4th, 2011

Read more

X-FAB and MFI Combine MEMS Foundry Offerings

X-FAB Silicon Foundries and MEMS Foundry Itzehoe GmbH (MFI) today announced they will join forces to address the market for high-volume MEMS (Micro-Electro-Mechanical Systems) and will combine their existing MEMS foundry capabilities and resources. X-FAB acquired a 25.5-percent shareholding of MFI, subject to antitrust approval, with the option to become the majority shareholder at a later date.

Posted: Feb 3rd, 2011

Read more

Fluidigm Unveils Its Most Advanced Nanofluidic Technology-Based Genome Analysis System

Fluidigm introduced the new BioMark HD Real-time PCR System, the company's most advanced instrument for genomic analysis ever. The BioMark HD System is designed for researchers who require the sensitivity and throughput needed to study gene expression down to the single-cell level -- especially those who have limited amounts of sample or study rare populations of cells.

Posted: Feb 2nd, 2011

Read more